参考文献 References
[1] Davies, M.J. and A.C. Thomas, Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J, 1985. 53(4): p. 363-73.
[2] Falk, E., Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J, 1983. 50(2): p. 127-34.
[3] Muller, J.E., G.H. Tofler, and P.H. Stone, Circadian variation and triggers of onset of acute cardiovascular disease. Circulation, 1989. 79(4): p. 733-43.
[4] Muller, J.E., et al., Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol, 1994. 23(3): p. 809-13.
[5] Virmani, R., et al., Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol, 2000. 20(5): p. 1262-75.
[6] Libby, P., Act local, act global: inflammation and the multiplicity of "vulnerable" coronary plaques. J Am Coll Cardiol, 2005. 45(10): p. 1600-2.
[7] Mauriello, A., et al., Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol, 2005. 45(10): p. 1585-93.
[8] Naghavi, M., et al., From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation, 2003. 108(14): p. 1664-72.
[9] Falk, E., Why do plaques rupture? Circulation, 1992. 86(6 Suppl): p. Iii30-42.
[10] Zhou, J., et al., Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes. Scand J Clin Lab Invest Suppl, 1999. 230: p. 3-11.
[11] Maehara, A., et al., Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol, 2002. 40(5): p. 904-10.
[12] Kotani, J., et al., Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction. Circulation, 2003. 107(23): p. 2889-93.
[13] Ozer, K. and M. Cilingiroglu, Vulnerable plaque: definition, detection, treatment, and future implications. Curr Atheroscler Rep, 2005. 7(2): p. 121-6.
[14] Huang, D., et al., Optical coherence tomography. Science, 1991. 254(5035): p. 1178-81.
[15] Kawasaki, M., et al., Diagnostic accuracy of optical coherence tomography and integrated backscatter intravascular ultrasound images for tissue characterization of human coronary plaques. J Am Coll Cardiol, 2006. 48(1): p. 81-8.
[16] Partida, R.A., et al., Plaque erosion: a new in vivo diagnosis and a potential major shift in the management of patients with acute coronary syndromes. Eur Heart J, 2018. 39(22): p. 2070-2076.
[17] Moreno, P.R., et al., Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy. Circulation, 2002. 105(8): p. 923-7.
[18] Moreno, P.R. and J.E. Muller, Identification of high-risk atherosclerotic plaques: a survey of spectroscopic methods. Curr Opin Cardiol, 2002. 17(6): p. 638-47.
[19] Caplan, J.D., et al., Near-infrared spectroscopy for the detection of vulnerable coronary artery plaques. J Am Coll Cardiol, 2006. 47(8 Suppl): p. C92-6.
[20] Waxman, S., F. Ishibashi, and J.D. Caplan, Rationale and use of near-infrared spectroscopy for detection of lipid-rich and vulnerable plaques. J Nucl Cardiol, 2007. 14(5): p. 719-28.
[21] Kandzari, D.E., et al., Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study). Am J Cardiol, 2004. 93(5): p. 636-9.
[22] Serruys, P.W., et al., A European multi-center trial investigating the anti-restenotic effect of intravascular sonotherapy after stenting of de novo lesions (EUROSPAH: EUROpean Sonotherapy Prevention of Arterial Hyperplasia). Int J Cardiovasc Intervent, 2004. 6(2): p. 53-60.
[23] Chou, T.M., et al., Photodynamic therapy: applications in atherosclerotic vascular disease with motexafin lutetium. Catheter Cardiovasc Interv, 2002. 57(3): p. 387-94.
[24] Jain, M., et al., Photodynamic therapy for the treatment of atherosclerotic plaque: Lost in translation? Cardiovasc Ther, 2017. 35(2).
[25] Nissen, S.E., Vulnerable Plaque and Einstein's Definition of Insanity. J Am Coll Cardiol, 2020. 75(12): p. 1383-1385.
[26] Eijgelaar, W.J., S. Heeneman, and M.J. Daemen, The vulnerable patient: refocusing on the plaque? Thromb Haemost, 2009. 102(2): p. 231-9.
[27] Naghavi, M., et al., From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation, 2003. 108(15): p. 1772-8.
[28] 张园园, et al., 辛伐他汀、丙丁酚和卡托普利在动脉粥样硬化斑块消退中的作用及与金属蛋白酶1和组织抑制物1基因表达的关系. 中国动脉硬化杂志, 2003(05): p. 401-404.
[29] Fernández-Friera, L., B. Ibáñez, and V. Fuster, Imaging subclinical atherosclerosis: is it ready for prime time? A review. J Cardiovasc Transl Res, 2014. 7(7): p. 623-34.
[30] Falk, E., P.K. Shah, and V. Fuster, Coronary plaque disruption. Circulation, 1995. 92(3): p. 657-71.
[31] Libby, P., et al., Reassessing the Mechanisms of Acute Coronary Syndromes. Circ Res, 2019. 124(1): p. 150-160.
[32] Ahmadi, A., et al., From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events: JACC State-of-the-Art Review. J Am Coll Cardiol, 2019. 74(12): p. 1608-1617.